Clover Health Investments (NASDAQ: CLOV) reported Q3 EPS of ($0.05), $0.04 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $479.1 million versus the consensus estimate of $467.18 million.

GUIDANCE:

Clover Health Investments sees FY2025 revenue of $1.85-1.88 billion, versus the consensus of $1.888 billion.

2026 Financial Outlook:

While the Company expects to provide formal full-year 2026 guidance next year, Clover anticipates the following profitability drivers to achieve full-year GAAP Net Income in 2026:

Favorable financial impact related to the upcoming 4.0 Star payment year for 2026
Continued strong cohort management and a focus on returning member retention
Favorable 2026 CMS final rate update
Increased Part D direct subsidy
Continued impact from cost efficiency initiatives to optimize variable, fixed, and growth SG&A

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.